CAMBRIDGE, Mass., Feb. 3 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated will webcast its presentations at the 2006 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 8, 2006 and at the Eighth Annual BIO CEO and Investor Conference on February 14, 2006.
Joshua Boger, Ph.D., Chairman, President and Chief Executive Officer of Vertex will present at both conferences. Vertex’s presentation and discussion at the Merrill Lynch conference will be conducted on February 8, 2006 at 8:40 a.m. EST and will be audio webcast only. At the BIO CEO and Investor Conference, Dr. Boger will deliver a corporate presentation on Tuesday, February 14, 2006 at 12:00 p.m. EST. In addition, Dr. Boger will participate in the Infectious Disease: Breakthroughs in Hepatitis Focus Session at 9:00 a.m. EST on that day. This Focus Session will also be webcast.
The presentations will be webcast live and may be accessed by visiting the Vertex website at http://www.vrtx.com. A replay of the webcasts will also be available on the Company’s website for two weeks following the presentations. To access the webcasts, go to Vertex’s website and select the ‘Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference’ or the ‘BIO CEO and Investor Conference’ or the ‘BIO CEO Breakthroughs in Hepatitis Focus Session’ from the ‘Events Calendar.’ To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex’s product pipeline is principally focused on viral diseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex’s press releases are available at http://www.vrtx.com. Vertex Contact: Lora Pike, Manager, Investor Relations, (617) 444-6755
Vertex Pharmaceuticals Incorporated
CONTACT: Lora Pike, Manager, Investor Relations of Vertex, +1-617-444-6755
Web site: http://www.vrtx.com//
Company News On-Call: http://www.prnewswire.com/comp/938395.html /
